Oxford Asset Management »

Rapt Therapeutics shares owned by Oxford Asset Management

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Oxford Asset Management from 13F filings

Historical chart of Oxford Asset Management investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Oxford Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Oxford Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $122k 14k 8.98

More positions owned by Oxford Asset Management

Stellantis SHS (STLA)
Draftkings Com Cl A (DKNG)
Cannae Holdings (CNNE)
Geopark Usd Shs (GPRK)
Philip Morris International (PM)
Adobe Systems Incorporated (ADBE)
Overseas Shipholding Group I Cl A New (OSG)
Zoetis Cl A (ZTS)
Snap Cl A (SNAP)
Alphabet Cap Stk Cl A (GOOGL)
R1 RCM (RCM)
Medical Properties Trust Call Option (MPW)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Archer Daniels Midland Company (ADM)
Cooper Cos (COO)

View all positions for Oxford Asset Management

Top funds holding Rapt Therapeutics

FMR
Column Group
Vanguard Group
BlackRock
T. Rowe Price Associates
Morgan Stanley
Kingdon Capital Management
Perceptive Advisors
Geode Capital Management
Redmile Group
State Street Corporation
Euclidean Capital
Affinity Asset Advisors
Dimensional Fund Advisors
Alphabet

View all funds holding Rapt Therapeutics